Lipidomic Analysis of the FIELD Trial: Mechanism of Action and Prediction of Response to Fenofibrate Treatment in Type 2 Diabetes

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1044709

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Patients with type 2 diabetes have abnormal blood lipids leading to an increased risk of cardiovascular disease. This risk can be decreased by fenofibrate treatment. However, not all patients show the same response to fenofibrate and so it is not clear who will benefit and who will not benefit from treatment. In this project we will develop a test to identify those patients who respond to and benefit from fenofibrate treatment. This will lead to the better outcomes for patients.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $643,323.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biochemistry: Lipids

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular disease prevention | lipid metabolism | mass spectrometry | mechanism of action | treatment efficacy

Related Links